Raushan T Kurmasheva

  • 1490 Citations
  • 22 h-Index
20052020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 1490 Citations
  • 22 h-Index
  • 62 Article
  • 6 Review article
  • 2 Short survey
  • 1 Chapter
Filter
Article
2020

Evaluation of VTP-50469, a menin-MLL1 inhibitor, against Ewing sarcoma xenograft models by the pediatric preclinical testing consortium

Kurmasheva, R. T., Bandyopadhyay, A., Favours, E., Pozo, V. D., Ghilu, S., Phelps, D. A., McGeehan, G. M., Erickson, S. W., Smith, M. A. & Houghton, P. J., Jul 1 2020, In : Pediatric Blood and Cancer. 67, 7, e28284.

Research output: Contribution to journalArticle

Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium

Harrison, D. J., Gill, J. D., Roth, M. E., Zhang, W., Teicher, B., Erickson, S., Gatto, G., Kurmasheva, R. T., Houghton, P. J., Smith, M. A., Kolb, E. A. & Gorlick, R., Jun 1 2020, In : Pediatric Blood and Cancer. 67, 6, e28222.

Research output: Contribution to journalArticle

Preclinical evaluation of the combination of AZD1775 and irinotecan against selected pediatric solid tumors: A Pediatric Preclinical Testing Consortium report

Kolb, E. A., Houghton, P. J., Kurmasheva, R. T., Mosse, Y. P., Maris, J. M., Erickson, S. W., Guo, Y., Teicher, B. A., Smith, M. A. & Gorlick, R., May 1 2020, In : Pediatric Blood and Cancer. 67, 5, e28098.

Research output: Contribution to journalArticle

Prospective use of the single-mouse experimental design for the evaluation of PLX038A

Ghilu, S., Li, Q., Fontaine, S. D., Santi, D. V., Kurmasheva, R. T., Zheng, S. & Houghton, P. J., Feb 1 2020, In : Cancer chemotherapy and pharmacology. 85, 2, p. 251-263 13 p.

Research output: Contribution to journalArticle

2019

Broad spectrum activity of the checkpoint kinase 1 inhibitor prexasertib as a single agent or chemopotentiator across a range of preclinical pediatric tumor models

Lowery, C. D., Dowless, M., Renschler, M., Blosser, W., VanWye, A. B., Stephens, J. R., Iversen, P. W., Lin, A. B., Beckmann, R. P., Krytska, K., Cole, K. A., Maris, J. M., Hawkins, D. S., Rubin, B. P., Kurmasheva, R. T., Houghton, P. J., Gorlick, R., Anders Kolb, E., Kang, M. H., Patrick Reynolds, C. & 4 others, Erickson, S. W., Teicher, B. A., Smith, M. A. & Stancato, L. F., Apr 1 2019, In : Clinical Cancer Research. 25, 7, p. 2278-2289 12 p.

Research output: Contribution to journalArticle

12 Scopus citations

Challenges and opportunities for childhood cancer drug development

Houghton, P. J. & Kurmasheva, R. T., Oct 1 2019, In : Pharmacological Reviews. 71, 4, p. 671-697 27 p.

Research output: Contribution to journalArticle

Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models

Kurmasheva, R. T., Bandyopadhyay, A. M., Favours, E., Del Pozo, V., Ghilu, S., Phelps, D. A., Erickson, S. W., Peer, C. J., Figg, W. D., Smith, M. A. & Houghton, P. J., Aug 2019, In : Pediatric Blood and Cancer. 66, 8, e27820.

Research output: Contribution to journalArticle

3 Scopus citations

Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design

Rokita, J. L., Rathi, K. S., Cardenas, M. F., Upton, K. A., Jayaseelan, J., Cross, K. L., Pfeil, J., Egolf, L. E., Way, G. P., Farrel, A., Kendsersky, N. M., Patel, K., Gaonkar, K. S., Modi, A., Berko, E. R., Lopez, G., Vaksman, Z., Mayoh, C., Nance, J., McCoy, K. & 49 others, Haber, M., Evans, K., McCalmont, H., Bendak, K., Böhm, J. W., Marshall, G. M., Tyrrell, V., Kalletla, K., Braun, F. K., Qi, L., Du, Y., Zhang, H., Lindsay, H. B., Zhao, S., Shu, J., Baxter, P., Morton, C., Kurmashev, D., Zheng, S., Chen, Y., Bowen, J., Bryan, A. C., Leraas, K. M., Coppens, S. E., Doddapaneni, H. V., Momin, Z., Zhang, W., Sacks, G. I., Hart, L. S., Krytska, K., Mosse, Y. P., Gatto, G. J., Sanchez, Y., Greene, C. S., Diskin, S. J., Vaske, O. M., Haussler, D., Gastier-Foster, J. M., Kolb, E. A., Gorlick, R., Li, X. N., Reynolds, C. P., Kurmasheva, R. T., Houghton, P. J., Smith, M. A., Lock, R. B., Raman, P., Wheeler, D. A. & Maris, J. M., Nov 5 2019, In : Cell Reports. 29, 6, p. 1675-1689.e9

Research output: Contribution to journalArticle

Open Access
5 Scopus citations

Nanoformulation of Talazoparib Increases Maximum Tolerated Doses in Combination With Temozolomide for Treatment of Ewing Sarcoma

Baldwin, P., Likhotvorik, R., Baig, N., Cropper, J., Carlson, R., Kurmasheva, R. & Sridhar, S., Dec 17 2019, In : Frontiers in Oncology. 9, 1416.

Research output: Contribution to journalArticle

Open Access

Preclinical activity of the antibody-drug conjugate denintuzumab mafodotin (SGN-CD19A) against pediatric acute lymphoblastic leukemia xenografts

Jones, L., McCalmont, H., Evans, K., Mayoh, C., Kurmasheva, R. T., Billups, C. A., Houghton, P. J., Smith, M. A. & Lock, R. B., Jan 1 2019, In : Pediatric Blood and Cancer. e27765.

Research output: Contribution to journalArticle

2 Scopus citations
2018

Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models

Bandyopadhyay, A., Favours, E., Phelps, D. A., Pozo, V. D., Ghilu, S., Kurmashev, D., Michalek, J., Trevino, A., Guttridge, D., London, C., Hirotani, K., Zhang, L., Kurmasheva, R. T. & Houghton, P. J., Feb 1 2018, In : Pediatric Blood and Cancer. 65, 2, e26870.

Research output: Contribution to journalArticle

3 Scopus citations

Initial testing (stage 1) of M6620 (formerly VX-970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program

Kurmasheva, R. T., Kurmashev, D., Reynolds, C. P., Kang, M., Wu, J., Houghton, P. J. & Smith, M. A., Feb 1 2018, In : Pediatric Blood and Cancer. 65, 2, e26825.

Research output: Contribution to journalArticle

9 Scopus citations
2017

Bioluminescence imaging enhances analysis of drug responses in a patient-derived xenograft model of pediatric ALL

Jones, L., Richmond, J., Evans, K., Carol, H., Jing, D., Kurmasheva, R. T., Billups, C. A., Houghton, P. J., Smith, M. A. & Lock, R. B., Jul 15 2017, In : Clinical Cancer Research. 23, 14, p. 3744-3755 12 p.

Research output: Contribution to journalArticle

8 Scopus citations

Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program

Kurmasheva, R. T., Sammons, M., Favours, E., Wu, J., Kurmashev, D., Cosmopoulos, K., Keilhack, H., Klaus, C. R., Houghton, P. J. & Smith, M. A., Mar 1 2017, In : Pediatric Blood and Cancer. 64, 3, e26218.

Research output: Contribution to journalArticle

37 Scopus citations

Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing program

Lock, R., Carol, H., Maris, J. M., Kolb, E. A., Gorlick, R., Reynolds, C. P., Kang, M. H., Keir, S. T., Wu, J., Purmal, A., Gudkov, A., Kurmashev, D., Kurmasheva, R. T., Houghton, P. J. & Smith, M. A., Apr 1 2017, In : Pediatric Blood and Cancer. 64, 4, e26263.

Research output: Contribution to journalArticle

5 Scopus citations

Initial testing of VS-4718, a novel inhibitor of focal adhesion kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program

Kurmasheva, R. T., Gorlick, R., Kolb, E. A., Keir, S. T., Maris, J. M., Lock, R. B., Carol, H., Kang, M., Reynolds, C. P., Wu, J., Houghton, P. J. & Smith, M. A., Apr 1 2017, In : Pediatric Blood and Cancer. 64, 4, e26304.

Research output: Contribution to journalArticle

4 Scopus citations
2016

Acute sensitivity of Ph-like acute lymphoblastic leukemia to the SMAC-mimetic birinapant

Richmond, J., Robbins, A., Evans, K., Beck, D., Kurmasheva, R. T., Billups, C. A., Carol, H., Heatley, S., Sutton, R., Marshall, G. M., White, D., Pimanda, J., Houghton, P. J., Smith, M. A. & Lock, R. B., Aug 1 2016, In : Cancer Research. 76, 15, p. 4579-4591 13 p.

Research output: Contribution to journalArticle

10 Scopus citations

Evaluation of alternative in vivo drug screening methodology: A single mouse analysis

Murphy, B., Yin, H., Maris, J. M., Kolb, E. A., Gorlick, R., Reynolds, C. P., Kang, M. H., Keir, S. T., Kurmasheva, R. T., Dvorchik, I., Wu, J., Billups, C. A., Boateng, N., Smith, M. A., Lock, R. B. & Houghton, P. J., Oct 1 2016, In : Cancer Research. 76, 19, p. 5798-5809 12 p.

Research output: Contribution to journalArticle

19 Scopus citations

Initial Testing (Stage 1) of MK-8242—A Novel MDM2 Inhibitor—by the Pediatric Preclinical Testing Program

Kang, M. H., Reynolds, C. P., Kolb, E. A., Gorlick, R., Carol, H., Lock, R., Keir, S. T., Maris, J. M., Wu, J., Lyalin, D., Kurmasheva, R. T., Houghton, P. J. & Smith, M. A., Oct 1 2016, In : Pediatric Blood and Cancer. 63, 10, p. 1744-1752 9 p.

Research output: Contribution to journalArticle

12 Scopus citations

Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program

Gorlick, R., Kolb, E. A., Keir, S. T., Maris, J. M., Lock, R. B., Carol, H., Reynolds, C. P., Kang, M. H., Billups, C. A., Collins, J., Kurmashev, D., Kurmasheva, R. T., Houghton, P. J. & Smith, M. A., Mar 1 2016, In : Pediatric Blood and Cancer. 63, 3, p. 443-450 8 p.

Research output: Contribution to journalArticle

Pharmacodynamic and genomic markers associated with response to the XPO1/CRM1 inhibitor selinexor (KPT-330): A report from the pediatric preclinical testing program

Attiyeh, E. F., Maris, J. M., Lock, R., Reynolds, C. P., Kang, M. H., Carol, H., Gorlick, R., Kolb, E. A., Keir, S. T., Wu, J., Landesman, Y., Shacham, S., Lyalin, D., Kurmasheva, R. T., Houghton, P. J. & Smith, M. A., Feb 1 2016, In : Pediatric Blood and Cancer. 63, 2, p. 276-286 11 p.

Research output: Contribution to journalArticle

9 Scopus citations

Quantitative phosphotyrosine profiling of patient-derived xenografts identifies therapeutic targets in pediatric leukemia

Dolai, S., Sia, K. C. S., Robbins, A. K., Zhong, L., Heatley, S. L., Vincent, T. L., Hochgräfe, F., Sutton, R., Kurmasheva, R. T., Revesz, T., White, D. L., Houghton, P. J., Smith, M. A., Teachey, D. T., Daly, R. J., Raftery, M. J. & Lock, R. B., May 1 2016, In : Cancer Research. 76, 9, p. 2766-2777 12 p.

Research output: Contribution to journalArticle

7 Scopus citations

Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia

Khaw, S. L., Suryani, S., Evans, K., Richmond, J., Robbins, A., Kurmasheva, R. T., Billups, C. A., Erickson, S. W., Guo, Y., Houghton, P. J., Smith, M. A., Carol, H., Roberts, A. W., Huang, D. C. S. & Lock, R. B., Sep 8 2016, In : Blood. 128, 10, p. 1382-1395 14 p.

Research output: Contribution to journalArticle

51 Scopus citations
2015

AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia

Manesh, D. M., El-Hoss, J., Evans, K., Richmond, J., Toscan, C. E., Bracken, L. S., Hedrick, A., Sutton, R., Marshall, G. M., Wilson, W. R., Kurmasheva, R. T., Billups, C., Houghton, P. J., Smith, M. A., Carol, H. & Lock, R. B., Sep 3 2015, In : Blood. 126, 10, p. 1193-1202 10 p.

Research output: Contribution to journalArticle

27 Scopus citations

Effective targeting of the P53-MDM2 axis in preclinical models of infant MLL-rearranged acute lymphoblastic leukemia

Richmond, J., Carol, H., Evans, K., High, L., Mendomo, A., Robbins, A., Meyer, C., Venn, N. C., Marschalek, R., Henderson, M., Sutton, R., Kurmasheva, R. T., Kees, U. R., Houghton, P. J., Smith, M. A. & Lock, R. B., Mar 15 2015, In : Clinical Cancer Research. 21, 6, p. 1395-1405 11 p.

Research output: Contribution to journalArticle

27 Scopus citations

Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia

Suryani, S., Bracken, L. S., Harvey, R. C., Sia, K. C. S., Carol, H., Chen, I. M., Evans, K., Dietrich, P. A., Roberts, K. G., Kurmasheva, R. T., Billups, C. A., Mullighan, C. G., Willman, C. L., Loh, M. L., Hunger, S. P., Houghton, P. J., Smith, M. A. & Lock, R. B., Feb 1 2015, In : Molecular cancer therapeutics. 14, 2, p. 364-374 11 p.

Research output: Contribution to journalArticle

28 Scopus citations

Inhibition of MDM2 by RG7388 confers hypersensitivity to X-radiation in xenograft models of childhood sarcoma

Phelps, D., Bondra, K., Seum, S., Chronowski, C., Leasure, J., Kurmasheva, R. T., Middleton, S., Wang, D., Mo, X. & Houghton, P. J., Aug 1 2015, In : Pediatric Blood and Cancer. 62, 8, p. 1345-1352 8 p.

Research output: Contribution to journalArticle

15 Scopus citations

Inhibition of MEK confers hypersensitivity to X-radiation in the context of BRAF mutation in a model of childhood astrocytoma

Studebaker, A., Bondra, K., Seum, S., Shen, C., Phelps, D. A., Chronowski, C., Leasure, J., Smith, P. D., Kurmasheva, R. T., Mo, X., Fouladi, M. & Houghton, P. J., Jan 1 2015, In : Pediatric Blood and Cancer. 62, 10, p. 1768-1774 7 p.

Research output: Contribution to journalArticle

5 Scopus citations

Initial testing (stage 1) of BAL101553, a novel tubulin binding agent, by the pediatric preclinical testing program

Kolb, E. A., Gorlick, R., Keir, S. T., Maris, J. M., Kang, M. H., Reynolds, C. P., Lock, R. B., Carol, H., Wu, J., Kurmasheva, R. T., Houghton, P. J. & Smith, M. A., Jun 1 2015, In : Pediatric Blood and Cancer. 62, 6, p. 1106-1109 4 p.

Research output: Contribution to journalArticle

4 Scopus citations

Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing program

Reynolds, C. P., Kang, M. H., Maris, J. M., Kolb, E. A., Gorlick, R., Wu, J., Kurmasheva, R. T., Houghton, P. J. & Smith, M. A., Nov 1 2015, In : Pediatric Blood and Cancer. 62, 11, p. 1897-1905 9 p.

Research output: Contribution to journalArticle

9 Scopus citations

Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673

Smith, M. A., Hampton, O. A., Reynolds, C. P., Kang, M. H., Maris, J. M., Gorlick, R., Kolb, E. A., Lock, R., Carol, H., Keir, S. T., Wu, J., Kurmasheva, R. T., Wheeler, D. A. & Houghton, P. J., Jan 1 2015, In : Pediatric Blood and Cancer. 62, 1, p. 91-98 8 p.

Research output: Contribution to journalArticle

45 Scopus citations

Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane®) by the Pediatric Preclinical Testing Program (PPTP)

Houghton, P. J., Kurmasheva, R. T., Kolb, E. A., Gorlick, R., Maris, J. M., Wu, J., Tong, Z., Arnold, M. A., Chatterjee, M., Williams, T. M. & Smith, M. A., Jul 1 2015, In : Pediatric Blood and Cancer. 62, 7, p. 1214-1221 8 p.

Research output: Contribution to journalArticle

20 Scopus citations

Synergistic activity of PARP inhibition by talazoparib (BMN 673) with temozolomide in pediatric Cancer Models in the Pediatric Preclinical Testing Program

Smith, M. A., Reynolds, C. P., Kang, M. H., Kolb, E. A., Gorlick, R., Carol, H., Lock, R. B., Keir, S. T., Maris, J. M., Billups, C. A., Lyalin, D., Kurmasheva, R. T. & Houghton, P. J., Feb 15 2015, In : Clinical Cancer Research. 21, 4, p. 819-832 14 p.

Research output: Contribution to journalArticle

63 Scopus citations
2014

Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenografts

Suryani, S., Carol, H., Chonghaile, T. N. I., Frismantas, V., Sarmah, C., High, L., Bornhauser, B., Cowley, M. J., Szymanska, B., Evans, K., Boehm, I., Tonna, E., Jones, L., Manesh, D. M. O., Kurmasheva, R. T., Billups, C., Kaplan, W., Letai, A., Bourquin, J. P., Houghton, P. J. & 2 others, Smith, M. A. & Lock, R. B., Sep 1 2014, In : Clinical cancer research : an official journal of the American Association for Cancer Research. 20, 17, p. 4520-4531 12 p.

Research output: Contribution to journalArticle

44 Scopus citations

FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene

Singh, M., Leasure, J. M., Chronowski, C., Geier, B., Bondra, K., Duan, W., Hensley, L. A., Villalona-Calero, M., Li, N., Vergis, A. M., Kurmasheva, R. T., Shen, C., Woods, G., Sebastian, N., Fabian, D., Kaplon, R., Hammond, S., Palanichamy, K., Chakravarti, A. & Houghton, P. J., Jul 15 2014, In : Clinical Cancer Research. 20, 14, p. 3884-3895 12 p.

Research output: Contribution to journalArticle

5 Scopus citations

Initial solid tumor testing (Stage 1) of AZD1480, an inhibitor of Janus kinases 1 and 2 by the pediatric preclinical testing program

Houghton, P. J., Kurmasheva, R. T., Lyalin, D., Maris, J. M., Kolb, E. A., Gorlick, R., Reynolds, C. P., Kang, M. H., Keir, S. T., Wu, J. & Smith, M. A., Nov 1 2014, In : Pediatric Blood and Cancer. 61, 11, p. 1972-1979 8 p.

Research output: Contribution to journalArticle

4 Scopus citations

Initial testing (stage 1) of glembatumumab vedotin (CDX-011) by the pediatric preclinical testing program

Kolb, E. A., Gorlick, R., Billups, C. A., Hawthorne, T., Kurmasheva, R. T., Houghton, P. J. & Smith, M. A., Oct 2014, In : Pediatric Blood and Cancer. 61, 10, p. 1816-1821 6 p.

Research output: Contribution to journalArticle

20 Scopus citations

Initial testing (Stage 1) of TAK-701, a humanized hepatocyte growth factor binding antibody, by the pediatric preclinical testing program

Houghton, P. J., Kurmasheva, R. T., Kolb, E. A., Wu, J., Gorlick, R., Maris, J. M. & Smith, M. A., Feb 2014, In : Pediatric Blood and Cancer. 61, 2, p. 380-382 3 p.

Research output: Contribution to journalArticle

1 Scopus citations

Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program

Carol, H., Gorlick, R., Kolb, E. A., Morton, C. L., Manesh, D. M., Keir, S. T., Reynolds, C. P., Kang, M. H., Maris, J. M., Wozniak, A., Hickson, I., Lyalin, D., Kurmasheva, R. T., Houghton, P. J., Smith, M. A. & Lock, R., Feb 2014, In : Pediatric Blood and Cancer. 61, 2, p. 245-252 8 p.

Research output: Contribution to journalArticle

20 Scopus citations

Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing program

Kang, M. H., Reynolds, C. P., Maris, J. M., Gorlick, R., Kolb, E. A., Lock, R., Carol, H., Keir, S. T., Wu, J., Lyalin, D., Kurmasheva, R. T., Houghton, P. J. & Smith, M. A., Jan 1 2014, In : Pediatric Blood and Cancer. 61, 8, p. 1486-1489 4 p.

Research output: Contribution to journalArticle

14 Scopus citations

Initial testing (stage 1) of the notch inhibitor PF-03084014, by the pediatric preclinical testing program

Carol, H., Maris, J. M., Kang, M. H., Reynolds, C. P., Kolb, E. A., Gorlick, R., Keir, S. T., Wu, J., Kurmasheva, R. T., Houghton, P. J., Smith, M. A. & Lock, R. B., 2014, In : Pediatric Blood and Cancer. 61, 8, p. 1493-1496 4 p.

Research output: Contribution to journalArticle

5 Scopus citations

Initial testing (stage 1) of the polo-like kinase inhibitor volasertib (BI 6727), by the pediatric preclinical testing program

Gorlick, R., Kolb, E. A., Keir, S. T., Maris, J. M., Reynolds, C. P., Kang, M. H., Carol, H., Lock, R., Billups, C. A., Kurmasheva, R. T., Houghton, P. J. & Smith, M. A., Jan 2014, In : Pediatric Blood and Cancer. 61, 1, p. 158-164 7 p.

Research output: Contribution to journalArticle

36 Scopus citations

Initial testing (stage 1) of the topoisomerase II inhibitor pixantrone, by the pediatric preclinical testing program

Kurmasheva, R. T., Reynolds, C. P., Kang, M. H., Allievi, C., Houghton, P. J. & Smith, M. A., May 2014, In : Pediatric Blood and Cancer. 61, 5, p. 922-924 3 p.

Research output: Contribution to journalArticle

4 Scopus citations

ΔNp63 promotes pediatric neuroblastoma and osteosarcoma by regulating tumor angiogenesis

Bid, H. K., Roberts, R. D., Cam, M., Audino, A., Kurmasheva, R. T., Lin, J., Houghton, P. J. & Cam, H., Jan 1 2014, In : Cancer Research. 74, 1, p. 320-329 10 p.

Research output: Contribution to journalArticle

32 Scopus citations
2013

Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma

Bid, H. K., Kibler, A., Phelps, D. A., Manap, S., Xiao, L., Lin, J., Capper, D., Oswald, D., Geier, B., DeWire, M., Smith, P. D., Kurmasheva, R. T., Mo, X., Fernandez, S. & Houghton, P. J., Dec 15 2013, In : Clinical Cancer Research. 19, 24, p. 6716-6729 14 p.

Research output: Contribution to journalArticle

34 Scopus citations

Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing program

Kolb, E. A., Gorlick, R., Reynolds, C. P., Kang, M. H., Carol, H., Lock, R., Keir, S. T., Maris, J. M., Billups, C. A., Desjardins, C., Kurmasheva, R. T., Houghton, P. J. & Smith, M. A., Aug 1 2013, In : Pediatric Blood and Cancer. 60, 8, p. 1325-1332 8 p.

Research output: Contribution to journalArticle

52 Scopus citations

Initial testing (stage 1) of ganetespib, an Hsp90 inhibitor, by the pediatric preclinical testing program

Lock, R. B., Carol, H., Maris, J. M., Kang, M. H., Reynolds, C. P., Kolb, E. A., Gorlick, R., Keir, S. T., Billups, C. A., Kurmasheva, R. T., Houghton, P. J. & Smith, M. A., Jul 2013, In : Pediatric Blood and Cancer. 60, 7, p. E42-E45

Research output: Contribution to journalArticle

7 Scopus citations

Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program

Keir, S. T., Maris, J. M., Reynolds, C. P., Kang, M. H., Kolb, E. A., Gorlick, R., Lock, R., Carol, H., Morton, C. L., Wu, J., Kurmasheva, R. T., Houghton, P. J. & Smith, M. A., May 2013, In : Pediatric Blood and Cancer. 60, 5, p. 783-790 8 p.

Research output: Contribution to journalArticle

10 Scopus citations

Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program

Wood, A. C., Maris, J. M., Gorlick, R., Kolb, E. A., Keir, S. T., Reynolds, C. P., Kang, M. H., Wu, J., Kurmasheva, R. T., Whiteman, K., Houghton, P. J. & Smith, M. A., Nov 2013, In : Pediatric Blood and Cancer. 60, 11, p. 1860-1867 8 p.

Research output: Contribution to journalArticle

14 Scopus citations

Initial testing (stage 1) of the phosphatidylinositol 3′ kinase inhibitor, SAR245408 (XL147) by the pediatric preclinical testing program

Reynolds, C. P., Kang, M. H., Carol, H., Lock, R., Gorlick, R., Kolb, E. A., Kurmasheva, R. T., Keir, S. T., Maris, J. M., Billups, C. A., Houghton, P. J. & Smith, M. A., May 2013, In : Pediatric Blood and Cancer. 60, 5, p. 791-798 8 p.

Research output: Contribution to journalArticle

15 Scopus citations